Alamar Biosciences’ mission is to transform the field of proteomics for early detection of cancer and other diseases. Following in the footsteps of genomics, proteomes will usher in a new era of precision health. The human plasma proteome, the complete set of proteins in human blood, has long been recognized as a gold mine of health and disease biomarkers. However, due to the low abundance and wide dynamic range of these proteins in the plasma, most of the plasma proteome has remained inaccessible with current technologies. We are creating the world’s most sensitive proteomics platform to unmask the deepest secrets of our proteome. Our fully automated, high throughput platform will empower new biomarker discoveries for early detection and prevention of common diseases.